| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.05 | 0.1 |